Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Treasury Shares (2024 - 2025)

Alto Neuroscience has reported Treasury Shares over the past 2 years, most recently at $27000.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $27000.0 for Q4 2025, down 50.0% from a year ago — trailing twelve months through Dec 2025 was $27000.0 (down 50.0% YoY), and the annual figure for FY2025 was $27000.0, down 50.0%.
  • Treasury Shares reached $27000.0 in Q4 2025 per ANRO's latest filing, roughly flat from $27000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $592748.0 in Q1 2024 and bottomed at $27000.0 in Q3 2025.